• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Rab-like protein 3 (RABL3)

ACP17332

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17332 Target NameRABL3
Target SynonymsRAB member of RAS oncogene family like 3; Rab-like protein 3; RABL3; RABL3_HUMANFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-236
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5HYI8
Background Information
  • Uniprot Id

    Q5HYI8

  • Target Species

    Human

  • Target Name

    RABL3

  • Target Full Name

    Rab-like protein 3

  • Target Function

    Required for KRAS signaling regulation and modulation of cell proliferation. Regulator of KRAS prenylation, and probably prenylation of other small GTPases. Required for lymphocyte development and function. Not required for myeloid cell development.

  • Target Protein Families

    Small GTPase superfamily, Rab family

  • Target Synonyms

    RAB member of RAS oncogene family like 3; Rab-like protein 3; RABL3; RABL3_HUMAN

  • Target Background

    Predicted to enable GTP binding activity; GTPase activity; and protein homodimerization activity. Involved in regulation of Ras protein signal transduction and regulation of protein lipidation. Predicted to be active in endomembrane system. Implicated in pancreatic cancer.

Inquire Recombinant Human Rab-like protein 3 (RABL3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification